Last reviewed · How we verify
GSK3640254 bis-hydrochloride salt capsule — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
GSK3640254 bis-hydrochloride salt capsule (GSK3640254 bis-hydrochloride salt capsule) — ViiV Healthcare.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GSK3640254 bis-hydrochloride salt capsule TARGET | GSK3640254 bis-hydrochloride salt capsule | ViiV Healthcare | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GSK3640254 bis-hydrochloride salt capsule CI watch — RSS
- GSK3640254 bis-hydrochloride salt capsule CI watch — Atom
- GSK3640254 bis-hydrochloride salt capsule CI watch — JSON
- GSK3640254 bis-hydrochloride salt capsule alone — RSS
Cite this brief
Drug Landscape (2026). GSK3640254 bis-hydrochloride salt capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/gsk3640254-bis-hydrochloride-salt-capsule. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab